Stage III Gastric Cancer (DBCOND0028835)

Identifiers

Synonyms
Stage Ⅲ Gastric Cancer / Gastric cancer stage III / Malignant neoplasm of stomach stage III / Gastric malignancy stage III / Stomach cancer stage III

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT02396498
SP Intravenous Chemotherapy Versus SP by HIPEC in Stage Ⅲ Patients After D2 GastrectomyNo drug interventionstreatment3unknown_status
NCT02969148
Laparoscopic Bursectomy and D2 Lymphadenectomy vs.Laparoscopic D2 Lymphadenectomy in Advanced Gastric CancerNo drug interventionstreatmentNot Availablerecruiting
NCT03550482
Oncoxin® and Quality of Life in Cancer PatientsNo drug interventionssupportive_care4completed
NCT06042998
A Multicenter, RCT Study of the Clinical Efficacy of Robotic and Laparoscopic Gastrectomy in Neoadjuvant Gastric CancerNo drug interventionstreatmentNot Availablerecruiting
NCT04515615
Adjuvant Chemotherapy in Combination With Camrelizumab for Stage III Gastric Cancer (FOCUS-02)treatment2active_not_recruiting
NCT04119622
Toripalimab Combined With Chemotherapy as Neoadjuvant Treatment of Gastric Cancertreatment2recruiting
NCT03788226
A Randomized Phase III Study Comparing POF With SOX/CAPOX/FOLFOX as a Postoperative Adjuvant Chemotherapy for Curatively Resected Stage III Gastric CancerNo drug interventionstreatment3unknown_status
NCT06342427
Stomach Cancer Exosome-based DetectionNo drug interventionsNot AvailableNot Availablecompleted
NCT04152889
A Study to Evaluate Camrelizumab in Combination With Docetaxel +S-1 as Adjuvant Treatment Therapy in Stage III Gastric Cancertreatment2unknown_status
NCT00103324
S0413 Lapatinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancertreatment2completed
NCT00028496
Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancertreatment1completed
NCT03368963
TAS102 in Combination With NAL-IRI in Advanced GI Cancerstreatment1 / 2recruiting
NCT00062374
Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junctiontreatment2completed
NCT00089362
Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumorstreatment1completed
NCT00006389
Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancertreatment2completed
NCT01561014
Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junctiontreatment1completed
NCT03154190
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With CancerNo drug interventionshealth_services_researchNot Availableunknown_status
NCT01191684
Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancertreatment1completed
NCT05253716
Immunonutritional Supplement After Total Gastrectomy in Patients With Stage III Gastric CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00004074
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neutreatment1completed
NCT00607594
Saracatinib in Treating Patients With Locally Advanced or Metastatic Stomach or Gastroesophageal Junction Cancertreatment2completed
NCT00087191
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerdiagnosticNot Availableterminated